Related Experiment Video
Updated: Aug 27, 2025
07:12
Targeting the Rat's Small Bowel: Long-Term Infusion into the Superior Mesenteric Artery
Published on: April 8, 2021
4.5K
Role of octreotide in small bowel bleeding
Anwar Khedr1, Esraa Elaraby Mahmoud2, Noura Attallah3
1Department of Internal Medicine, BronxCare Health System, Bronx, NY 10457, United States.
World Journal of Clinical Cases
|September 26, 2022
Summary
Octreotide, a somatostatin analog, effectively manages small bowel bleeding by improving platelet aggregation and reducing blood flow. This review highlights its clinical efficacy in improving patient outcomes and reducing mortality.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Gastrointestinal bleeding significantly impacts patient quality of life, necessitating extensive diagnostic and therapeutic measures.
- Small bowel bleeding, though less common, presents a persistent challenge for patients with unidentified bleeding sources.
Purpose of the Study:
- To review the clinical efficacy of octreotide in managing small bowel bleeding.
- To assess the impact of octreotide on morbidity and mortality associated with small bowel bleeding.
Main Methods:
- Literature review of studies on octreotide for small bowel bleeding.
- Analysis of octreotide's pharmacological mechanisms in controlling gastrointestinal bleeding.
Main Results:
- Octreotide demonstrates efficacy in controlling symptoms of gastrointestinal bleeding.
- Mechanisms include enhanced platelet aggregation, reduced splanchnic blood flow, and anti-angiogenic properties.
Conclusions:
- Octreotide is a valuable therapeutic option for small bowel bleeding.
- Further evaluation of its impact on patient morbidity and mortality is warranted.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
122
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
122
01:21Inflammatory Bowel Disease V: Surgical Management
195
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
195
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
655
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
655
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
394
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
394
01:29Inflammatory Bowel Disease IV: Pharmacological Management
174
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
174
01:17Drugs for Treatment of Diarrhea-Predominant IBS
270
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
270